STEPHANIE REEVES: Open Payments
NPI 1396306460 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 38 payments from 17 companies in 2025. Trend: 2023 $695 · 2024 $637 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $162 |
| PFIZER INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ABBVIE INC. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Indivior Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $24 |
Products named: Ozempic, NURTEC ODT, VRAYLAR, CAPLYTA, BREZTRI, SUBLOCADE, Rybelsus, Kerendia.
Industry payments across AL — which companies pay providers there.
